Article Details
Retrieved on: 2021-06-28 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The U.S. government will pause distribution of the monoclonal antibodies bamlanivimab and etesevimab, authorized for high-risk COVID-19 ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here